Potassium channels: molecular defects, diseases, and therapeutic opportunities.
about
Arylbenzazepines are potent modulators for the delayed rectifier K+ channel: a potential mechanism for their neuroprotective effectsIon channel gene expression in the inner earNeuronal and Cardiovascular Potassium Channels as Therapeutic Drug Targets: Promise and PitfallsNovel roles for hERG K(+) channels in cell proliferation and apoptosispH-Responsive, posttranslational regulation of the Trk1 potassium transporter by the type 1-related Ppz1 phosphatase.Peptidomimetic Star Polymers for Targeting Biological Ion ChannelsKv2.1 ablation alters glucose-induced islet electrical activity, enhancing insulin secretionDV21 decreases excitability of cortical pyramidal neurons and acts in epilepsy.Shock Wave-Induced Damage of a Protein by Void CollapseThe role of an inwardly rectifying K(+) channel (Kir4.1) in the inner ear and hearing loss.Potassium currents in isolated deiters' cells of Guinea pig.Molecular remodeling of ion channels, exchangers and pumps in atrial and ventricular myocytes in ischemic cardiomyopathy.Molecular diversity and functional evolution of scorpion potassium channel toxinsThe potassium channel Ether à go-go is a novel prognostic factor with functional relevance in acute myeloid leukemiaThe application of the Escherichia coli giant spheroplast for drug screening with automated planar patch clamp systemElectrophysiological remodeling in heart failureUnraveling monogenic channelopathies and their implications for complex polygenic diseaseOpen conformation of hERG channel turrets revealed by a specific scorpion toxin BmKKx2Probing the pH-dependent structural features of alpha-KTx12.1, a potassium channel blocker from the scorpion Tityus serrulatusAn integrative model of ion regulation in yeastA practical approach to genetic hypokalemia.Multiscale model of dynamic neuromodulation integrating neuropeptide-induced signaling pathway activity with membrane electrophysiology.Plectasin, first animal toxin-like fungal defensin blocking potassium channels through recognizing channel pore region.Electrostatic interactions in the channel cavity as an important determinant of potassium channel selectivity.Effects of thymol on calcium and potassium currents in canine and human ventricular cardiomyocytes.hERG potassium channel blockage by scorpion toxin BmKKx2 enhances erythroid differentiation of human leukemia cells K562Rehabilitating drug-induced long-QT promoters: in-silico design of hERG-neutral cisapride analogues with retained pharmacological activity.High yield purification of full-length functional hERG K+ channels produced in Saccharomyces cerevisiae.Emerging new uses of phosphodiesterase-5 inhibitors in cardiovascular diseases.Molecular mechanisms of detrusor and corporal myocyte contraction: identifying targets for pharmacotherapy of bladder and erectile dysfunctionPolycomb-dependent repression of the potassium channel-encoding gene KCNA5 promotes cancer cell survival under conditions of stressNeuronal potassium channel openers in the management of epilepsy: role and potential of retigabine.The Effects of the KCNQ Openers Retigabine and Flupirtine on Myotonia in Mammalian Skeletal Muscle Induced by a Chloride Channel Blocker.S100 calcium binding proteins and ion channelsAntidystonic effects of Kv7 (KCNQ) channel openers in the dt sz mutant, an animal model of primary paroxysmal dystoniaMembrane-delimited inhibition of maxi-K channel activity by the intermediate conductance Ca2+-activated K channel.Cardioprotective effects of fatty acid amide hydrolase inhibitor URB694, in a rodent model of trait anxiety.Optimizing postoperative sexual function after radical prostatectomyPharmacological characterization of 1-nitrosocyclohexyl acetate, a long-acting nitroxyl donor that shows vasorelaxant and antiaggregatory effects.Ca2+ -activated K+ channel (KCa) stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction.
P2860
Q21091199-590C6959-14ED-4EFF-AA7B-B7D5BEE6BDC9Q24650344-3D43C7A2-4A56-40DA-9817-028956288E4AQ26798018-4356A00E-BB9A-4696-A3CE-BD2CA8234579Q27015660-A8D35FF3-3511-4EFE-8050-ADF2E51DDB71Q27937656-4AEE9A28-92B7-4331-894D-F9F692F037DDQ28550966-158D169B-3764-4256-B0D2-BDA8FEEA7FFEQ28588570-CC3BCBE6-5B1E-4877-BDAB-B7F5381FDF24Q29994691-929A386C-E729-4817-8BB2-7FBF489AF6AFQ30366106-EF82CBCF-4447-4B92-93BE-413183B599D9Q30414096-F8762F34-9EE9-46FE-9CE6-E6A5C5FF94FBQ30445278-759709DB-F24A-4C21-9C2D-84724EC02A05Q33525464-92D5BE4B-4E9A-4901-AF99-492FA549EE4DQ33708620-FB0897CB-5E57-4ED2-A5DB-C8C8BE4F9BB5Q33715775-6A4284D2-13E7-4258-AC5C-700A39AF15D9Q33782923-9D755447-9BB5-4D11-88C1-C46FB0E8103DQ33887264-D090353B-67BD-4E22-B8E9-59A582C5C582Q33905030-6B3CEB62-85A7-4F96-9D8D-3150DFD24497Q33938901-8210D9D4-5222-4A90-9424-97519FE2CFEFQ34403695-7CC06BDB-8733-437A-AF98-30296DC1BF96Q34558001-33A69C8D-90C5-4A62-9B55-F156D114EF59Q34584743-731B6F22-CC22-4F8D-92B4-B89E285252A9Q34863014-3C29486B-35A0-4575-AA8D-B2055E92DDCAQ35003632-EAC9B68B-8AAD-41C5-BA2C-219A85FF8613Q35039384-2365792F-67F4-44F1-893D-8C9674FBCFA4Q35044378-C1B635DC-92F9-48D2-9BB0-31FE288B1EBBQ35081094-83B44039-1501-43A4-AA65-34230C42079AQ35114020-5EF2125C-A840-4762-B85A-F36AF82B23DEQ35123689-0284E972-D350-4FB9-8E99-EAEAA3D9112BQ35500693-21A652A5-14BA-4DE9-A7E7-E37127028737Q35545755-1BB0D4D9-F6BC-4AD6-81FA-A014E4949AD2Q35672183-EF121DB8-38B3-49FF-B388-9A827D0F6031Q35683922-2BE161BF-FAB7-4A6B-9B06-ADD763D120DBQ35872543-4C442285-7F23-4B0C-B1F3-8F3C2275B91EQ35911792-F31E9BA4-2365-4CDB-AAF9-1676F48D3C71Q36054393-16926C31-D8C6-45EB-9AA9-3E212840A425Q36295587-FFA66848-843C-493E-91C7-A68025DF0B7FQ36367355-6F833C31-306A-4E7F-9A7E-20B5552C450EQ36379338-2789BB41-B53D-460F-A7AB-6C940A94A218Q36573243-2103B441-A76E-4DE3-B26D-428EA2251F0AQ36836444-3B5052FD-8D0A-4411-B0C4-DD9323902560
P2860
Potassium channels: molecular defects, diseases, and therapeutic opportunities.
description
2000 nî lūn-bûn
@nan
2000 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Potassium channels: molecular defects, diseases, and therapeutic opportunities.
@ast
Potassium channels: molecular defects, diseases, and therapeutic opportunities.
@en
Potassium channels: molecular defects, diseases, and therapeutic opportunities.
@nl
type
label
Potassium channels: molecular defects, diseases, and therapeutic opportunities.
@ast
Potassium channels: molecular defects, diseases, and therapeutic opportunities.
@en
Potassium channels: molecular defects, diseases, and therapeutic opportunities.
@nl
prefLabel
Potassium channels: molecular defects, diseases, and therapeutic opportunities.
@ast
Potassium channels: molecular defects, diseases, and therapeutic opportunities.
@en
Potassium channels: molecular defects, diseases, and therapeutic opportunities.
@nl
P2093
P1476
Potassium channels: molecular defects, diseases, and therapeutic opportunities
@en
P2093
Gopalakrishnan M
Sullivan JP
P304
P577
2000-12-01T00:00:00Z